论文信息 - Antifibrinolytic Therapy and Pulmonary Thromboembolism During Orthotopic Liver Transplantation - 字舞流文

Antifibrinolytic Therapy and Pulmonary Thromboembolism During Orthotopic Liver Transplantation

C. O'Connor | K. Tuman

[1] E. Jaurrieta,et al. Tranexamic Acid Reduces Red Cell Transfusion Better than &egr;-Aminocaproic Acid or Placebo in Liver Transplantation , 2000, Anesthesia and analgesia.

[2] L. Lindgren,et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study , 2000, The Lancet.

[3] M. Ramsay,et al. Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation , 1997, Anesthesia and analgesia.

[4] M. Ramsay,et al. Continuous Small-Dose Aprotinin Controls Fibrinolysis During Orthotopic Liver Transplantation , 1996, Anesthesia and analgesia.

[5] C. Ecoffey,et al. Comparative Effects of Small and Large Aprotinin Doses on Bleeding During Orthotopic Liver Transplantation , 1995, Anesthesia and analgesia.

[6] S. Mallett,et al. Impact of aprotinin on blood transfusion requirements in liver transplantation , 1993, Transfusion medicine.

[7] M. Frambach,et al. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss. , 1991, Thrombosis research.